Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries.

Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries. Epidemiol Psychiatr Sci. 2020 May 06;29:e126 Authors: Ostuzzi G, Gastaldon C, Petrini C, Godman B, Barbui C Abstract The principle of pragmatism in clinical trials has been broadly recognised as a way to close the gap between research and practice. In this contribution, we argue that the conduct of pragmatic clinical trials in Europe may be hampered by poor implementation of current European Union's Clinical Trial Regulation No. 536/2014. PMID: 32370820 [PubMed - in process]
Source: Epidemiology and Psychiatric Sciences - Category: Psychiatry Tags: Epidemiol Psychiatr Sci Source Type: research